Clinical Genetics Branch Eligibility Screening Survey | MicrobiomeTrials← Back to trialsNCT07005297
Clinical Genetics Branch Eligibility Screening Survey
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-10-29Est. Completion: 2035-01-01
Enrollment target: 1,000 participants Locations- National Cancer Institute, Rockville, Maryland, United States
Other microbiome trials you might be interested in
Melanoma
The purpose of this study is to pilot the use of community education and digital dermatology to increase the early detec…
Los Angeles, United StatesCompleted Dec 31, 2027
Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8
This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients …
Birmingham, United StatesEst. completion Dec 31, 2026
Lung Non-Squamous Non-Small Cell CarcinomaStage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8
This phase III trial studies whether pembrolizumab alone as a first-line treatment, followed by pemetrexed and carboplat…
Mobile, United StatesEst. completion Sep 30, 2027